期刊文献+

波生坦片的制备

Preparation of Bosentan Tablet
原文传递
导出
摘要 目的优化波生坦片的制剂处方,以解决波生坦溶出度不高,制剂不稳定的共性难题。方法采用湿法制粒后压片的工艺,以片剂的性状、溶出度、有关物质、晶型稳定性等为评价指标,比较不同处方制得的波生坦片,并与原研药相比较。结果优化后的处方制得的波生坦片,片面光洁美观,溶出效果好,晶型稳定,有关物质符合要求,且溶出行为和质量与原研药一致。结论该新处方增加了波生坦的溶出度,提高了制剂晶型的稳定性,制剂质量与原研药一致,且制备方法简单、可行、易于实现产业化大生产,值得推广。 OBJECTIVE To optimize the prescription of bosentan tablet, and in order to solve the common problem of dissolution and chemical stability. METHODS Tablets characters, dissolution, related substance and stability of crystal was used as the research index to compare the methods of preparating Bosentan tablet including original drugs, so as to get optimized method. RESULTS The tablets made by the best method (as tabletting after wet granulation after optimization) were one sided smooth and had beautiful appearance, high solubility, stable crystal and related substance according to requirement, especially the solubility activity and quality being compliant with original drug. CONCLUSION The new method can solve the problem of dissolution and chemical stability, can get tablets excellent quality of original drug, being simple and feasible to realize industrial production.
作者 刘杨 赖庆宽
出处 《中国现代应用药学》 CAS CSCD 2017年第12期1721-1726,共6页 Chinese Journal of Modern Applied Pharmacy
关键词 波生坦片 处方优化 晶型稳定性 Bosentan tablet prescription optimization stability of crystal
  • 相关文献

参考文献6

二级参考文献69

  • 1李艳洁,徐泳.用离散元模拟颗粒堆积问题[J].农机化研究,2005,27(2):57-59. 被引量:31
  • 2文耀智,吴永兰.西尼地平研究进展[J].郴州师范高等专科学校学报,2003,24(5):61-64. 被引量:2
  • 3於海明,龚红菊,韩英.谷物休止角圆盘式快速测试仪的设计与试验[J].粮油加工与食品机械,2005(12):75-76. 被引量:12
  • 4Badesch DB,Champion HC,Sanchez MA,et al.Diagnosis and as-sessment of pulmonary arterial hypertension[J].J Am Coll Cardi-ol,2009,54(1 Suppl):S55-S66.
  • 5Olschewski H,Hoeper MM,Behr J,et al.Long-term therapy withinhaled iloprost in patients with pulmonary hypertension[J].Re-spir Med,2010,104(5):731-740.
  • 6Baysal A,Bilsel S,Bulbul OG,et al.Comparison of the usage of in-travenous iloprost and nitroglycerin for pulmonary hypertension dur-ing valvular heart surgery[J].Heart Surg Forum,2006,9(1):E536-E542.
  • 7Fuso L,Baldi F,Di Perna A.Therapeutic strategies in pulmonaryhypertension[J].Front Pharmacol,2011,2:21.
  • 8Rosenkranzl S.Pulmonary hypertension:current diagnosis andtreatment[J].Clin Res Cardiol,2007,96(8):527-541.
  • 9Wong RC,Koh GM,Choong PH,et al.Oral sildenafil therapy im-proves health-related quality of Life and functional status in pulmo-nary arterial hypertension[J].Int J Cardiol,2007,119(3):400-402.
  • 10Lu XL,Xiong CM,Shan GL,et al.Sildenafil therapy for pulmonaryhypertension:a prospective study[J].Zhonghua Jie He He Hu XiZa Zhi,2011,34(6):419-423.

共引文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部